Lipella Pharmaceuticals Inc. (LIPO) Income Statement Analysis - Revenue, Earnings & Profitability Metrics - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Lipella Pharmaceuticals I...

    NASDAQ: LIPO · Real-Time Price · USD
    0.56
    -0.00 (-0.25%)
    At close: Oct 03, 2025, 11:22 AM
    0.56
    0.00%
    Pre-market: Oct 03, 2025, 11:22 AM EDT

    Lipella Pharmaceuticals Income Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Revenue
    		 536.36K 449.62K 184.16K 259.35K
    Cost of Revenue
    		 3.61M 3.04M 2.55M 1.46M
    Gross Profit
    		 -3.08M -2.59M -2.36M -1.2M
    Operating Income
    		 -5.08M -4.75M -2.59M -1.92M
    Interest Income
    		 64.28K 137.84K 1.68K 104.00
    Pretax Income
    		 -5.02M -4.62M -2.6M -1.87M
    Net Income
    		 -5.02M -4.62M -2.6M -1.87M
    Selling & General & Admin
    		 2M 2.16M 226.19K 718.38K
    Research & Development
    		 3.61M 3.04M 2.55M 1.46M
    Other Expenses
    		 -3.61M n/a -45 -1.46M
    Operating Expenses
    		 2M 2.16M 2.77M 718.38K
    Interest Expense
    		 n/a 10.85K 9.61K 6.83K
    Selling & Marketing Expenses
    		 n/a n/a n/a n/a
    Cost & Expenses
    		 -5.62M 5.2M 2.77M 2.18M
    Income Tax Expense
    		 n/a n/a -1.63K 6.73K
    Shares Outstanding (Basic)
    		 1.05M 749.83K 507.36K 466.48K
    Shares Outstanding (Diluted)
    		 1.05M 750.38K 507.58K 426.01K
    EPS (Basic)
    		 -4.79 -6.16 -5.12 -4
    EPS (Diluted)
    		 -4.79 -6.16 -5.12 -4.38
    EBITDA
    		 -5.01M -4.61M -2.59M -1.86M
    EBIT
    		 -5.02M -4.61M -2.59M -1.86M
    Depreciation & Amortization
    		 2.89K 1.69K 2.59M n/a

    Add to Watchlist